Glucosamine and chondroitin safety studies
Pro Research Analysisby 
Searched over 200M research papers
Safety Profile of Glucosamine and Chondroitin in Osteoarthritis Treatment
Multiple systematic reviews and meta-analyses have consistently found that glucosamine and chondroitin, whether used alone or in combination, have a strong safety profile for the management of osteoarthritis, particularly of the knee and hip. Across numerous randomized controlled trials, the incidence of adverse events for both glucosamine and chondroitin was similar to that of placebo, indicating that these supplements are generally well tolerated and safe for long-term use Rabade2024Meng2022Park2025+6 MORE.
Adverse Events and Tolerability
Studies show no significant difference in the rate of adverse events, serious adverse events, or withdrawals due to adverse events between patients taking glucosamine, chondroitin, their combination, or placebo. This suggests that these supplements do not increase the risk of side effects compared to not taking them at all Rabade2024Meng2022Park2025+5 MORE. In comparison to other pharmacologic treatments like celecoxib, glucosamine and chondroitin have a lower risk of gastrointestinal side effects .
Liver and Kidney Safety
A systematic review of over 2,000 publications found that pharmaceutical-grade, highly purified forms of chondroitin sulfate and glucosamine sulfate do not harm liver function. In fact, these compounds may have beneficial effects on liver health by reducing inflammation and supporting fat metabolism, further supporting their safety for long-term use .
Combination Therapy Safety
The combination of glucosamine and chondroitin has also been shown to be safe, with no increase in adverse events compared to single-agent therapy or placebo. This holds true even in studies with large sample sizes and diverse patient populations Meng2022Wang2022Zeng2015+1 MORE. The combination is as well tolerated as either supplement alone.
Conclusion
Glucosamine and chondroitin, both individually and in combination, are safe and well-tolerated options for the management of osteoarthritis. Their safety profile is comparable to placebo, with no significant increase in adverse events, and they may even offer additional liver-protective benefits. These findings support their continued use as a first-line or adjunctive therapy for osteoarthritis, especially for patients seeking alternatives to traditional pharmacologic treatments.
Sources and full results
Most relevant research papers on this topic
A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
Glucosamine and chondroitin sulfate supplements show an excellent safety profile and may provide initial treatment for knee osteoarthritis patients.
DOI